KARANPREET DOSANJH: Open Payments
NPI 1831773407 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 16 payments from 13 companies in 2025. Trend: 2023 $641 · 2024 $343 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $49 |
| UCB, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 1 | $36 |
| Mannkind Corporation | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: OTEZLA, TZIELD, AFREZZA, Nayzilam, The Cologuard Plus Collection Kit, BREZTRI, Rybelsus, UZEDY.
Industry payments across CA — which companies pay providers there.
